TOLERAGEN

Welcome to the Brand page for “TOLERAGEN”, which is offered here for Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, systemic lupus erythematosus; [ rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; grave's disease; myasthenia gravis; hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and goodpasture's syndrome ];.

Its status is currently believed to be active. Its class is unavailable. “TOLERAGEN” is believed to be currently owned by “LA JOLLA PHARMACEUTICAL COMPANY”.


Owner:
LA JOLLA PHARMACEUTICAL COMPANY
Owner Details
Description:
Pharmaceutical preparations for prevention and/or treatment of antibody-mediated diseases, systemic lupus erythematosus; [ Rh hemolytic disease of the newborn; antiphospholipid antibody syndrome; Grave's disease; myasthenia gravis; Hashimoto's thyroiditis; pemphigus; autoimmune hemolytic anemia; autoimmune thrombocytopenia purpura; antibody mediated infertility; Sjogre's syndrome; mixed connective tissue disease; glomerulonephritis and Goodpasture's syndrome ];
Categories: PHARMACEUTICAL PREPARATIONS PREVENTION OR